hexamethonium has been researched along with Toxemia in 2 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Toxemia: A condition produced by the presence of toxins or other harmful substances in the BLOOD.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| ZHUPANENKO, TI | 1 |
| MULCAHY, R | 1 |
2 other studies available for hexamethonium and Toxemia
| Article | Year |
|---|---|
[Treatment of late toxemias of pregnancy with hexonium combined with reserpine].
Topics: Female; Hexamethonium; Hexamethonium Compounds; Humans; Pre-Eclampsia; Pregnancy; Reserpine; Toxemia | 1963 |
The treatment of toxaemia of pregnancy with hexamethonium bitartrate.
Topics: Female; Hexamethonium; Muscle Relaxants, Central; Pre-Eclampsia; Pregnancy; Sepsis; Toxemia | 1952 |